Observational studyDrug design, development and therapy2021

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer.

Qingli Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.